TrialInternational urology and nephrology2025
Efficacy and safety of dual renin-angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR.
Mei Mei et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it